PMC:7172841 / 4965-5110 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T58","span":{"begin":75,"end":83},"obj":"Disease"},{"id":"T59","span":{"begin":75,"end":79},"obj":"Disease"},{"id":"T60","span":{"begin":109,"end":122},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T37","span":{"begin":38,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}

{"project":"LitCovid-sentences","denotations":[{"id":"T40","span":{"begin":0,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T29","span":{"begin":102,"end":119},"obj":"Phenotype"}],"attributes":[{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0032169"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T128","span":{"begin":31,"end":37},"obj":"UBERON:0002405;GO:0006955"},{"id":"T129","span":{"begin":38,"end":48},"obj":"GO:0042110"},{"id":"T130","span":{"begin":53,"end":66},"obj":"GO:0065007"},{"id":"T131","span":{"begin":75,"end":85},"obj":"SP_7"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}

{"project":"LitCovid-PubTator","denotations":[{"id":"284","span":{"begin":75,"end":85},"obj":"Species"},{"id":"285","span":{"begin":129,"end":136},"obj":"Species"},{"id":"306","span":{"begin":109,"end":119},"obj":"Disease"}],"attributes":[{"id":"A284","pred":"tao:has_database_id","subj":"284","obj":"Tax:2697049"},{"id":"A285","pred":"tao:has_database_id","subj":"285","obj":"Tax:9606"},{"id":"A306","pred":"tao:has_database_id","subj":"306","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We assessed the differences of immune activation and dysregulation between SARS-CoV-2 and other known severe infections in three patient cohorts:"}